DE69719320D1 - Kombination eines somatostatin analogs und eines rapamycins - Google Patents

Kombination eines somatostatin analogs und eines rapamycins

Info

Publication number
DE69719320D1
DE69719320D1 DE69719320T DE69719320T DE69719320D1 DE 69719320 D1 DE69719320 D1 DE 69719320D1 DE 69719320 T DE69719320 T DE 69719320T DE 69719320 T DE69719320 T DE 69719320T DE 69719320 D1 DE69719320 D1 DE 69719320D1
Authority
DE
Germany
Prior art keywords
combination
rapamycin
somatostatin analog
somatostatin
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69719320T
Other languages
English (en)
Other versions
DE69719320T2 (de
Inventor
Gisbert Weckbecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612171.0A external-priority patent/GB9612171D0/en
Priority claimed from GBGB9619310.7A external-priority patent/GB9619310D0/en
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE69719320D1 publication Critical patent/DE69719320D1/de
Publication of DE69719320T2 publication Critical patent/DE69719320T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69719320T 1996-06-11 1997-06-11 Kombination eines somatostatin analogs und eines rapamycins Expired - Lifetime DE69719320T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9612171.0A GB9612171D0 (en) 1996-06-11 1996-06-11 Organic compounds
GBGB9619310.7A GB9619310D0 (en) 1996-09-16 1996-09-16 Organic compounds
PCT/EP1997/003036 WO1997047317A1 (en) 1996-06-11 1997-06-11 Combination of a somatostatin analogue and a rapamycin

Publications (2)

Publication Number Publication Date
DE69719320D1 true DE69719320D1 (de) 2003-04-03
DE69719320T2 DE69719320T2 (de) 2003-12-11

Family

ID=26309485

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69719320T Expired - Lifetime DE69719320T2 (de) 1996-06-11 1997-06-11 Kombination eines somatostatin analogs und eines rapamycins

Country Status (10)

Country Link
US (1) US6362164B1 (de)
EP (1) EP0896544B1 (de)
JP (1) JP3784418B2 (de)
AT (1) ATE233098T1 (de)
AU (1) AU3257297A (de)
CA (1) CA2249439C (de)
DE (1) DE69719320T2 (de)
DK (1) DK0896544T3 (de)
ES (1) ES2193379T3 (de)
WO (1) WO1997047317A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145406A0 (en) 1999-03-29 2002-06-30 Procter & Gamble Melanocortin receptor ligands
ES2167189B1 (es) * 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
AU3095601A (en) * 2000-01-14 2001-07-24 Univ Pennsylvania O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
AU2016206379B2 (en) * 2001-02-19 2017-09-14 Novartis Ag Cancer Treatment
AU2011226833B9 (en) * 2001-02-19 2014-07-03 Novartis Ag Cancer treatment
AU2005201004A1 (en) * 2001-02-19 2005-03-24 Novartis Ag Cancer treatment
SI2762140T1 (sl) * 2001-02-19 2017-07-31 Novartis Ag Zdravljenje trdnih možganskih tumorjev z derivatom rapamicina
FI20031454A0 (fi) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
EP1522311A1 (de) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau
JP2007534337A (ja) * 2004-04-27 2007-11-29 ワイス ラパマイシン特異的メチラーゼを用いるラパマイシンの標識
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
SI1787658T1 (sl) 2005-11-10 2012-07-31 Chemi Spa Formulacije z trajnim sproščanjem somatostatin analognih inhibitorjev rastnega hormona
NO20220050A1 (no) 2005-11-21 2008-08-12 Novartis Ag Neuroendokrin tumorbehandling
JP2009254391A (ja) * 2006-07-18 2009-11-05 Tetsuhiko Katsumata ゴルフのボールマーカー用ホルダー及びアクセサリー
AU2011285297A1 (en) 2010-07-29 2013-02-07 Linak A/S Lifting column preferably for height-adjustable tables
CN109675041A (zh) * 2011-07-07 2019-04-26 美国癌症研究所 用于治疗癌症的系统、方法和制剂
US8933078B2 (en) 2011-07-14 2015-01-13 Research Cancer Institute Of America Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
US11890292B2 (en) 2017-02-27 2024-02-06 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
WO2018170457A1 (en) 2017-03-17 2018-09-20 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
JP7099717B2 (ja) 2019-09-30 2022-07-12 株式会社理研バイオ ソマトスタチン受容体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2239178B (en) * 1987-07-10 1991-11-27 Sandoz Ltd Somatostatin analogues for the treatment of breast cancer
GB9125660D0 (en) 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound

Also Published As

Publication number Publication date
CA2249439A1 (en) 1997-12-18
CA2249439C (en) 2009-09-08
WO1997047317A1 (en) 1997-12-18
ES2193379T3 (es) 2003-11-01
ATE233098T1 (de) 2003-03-15
DK0896544T3 (da) 2003-05-05
JP2000514415A (ja) 2000-10-31
AU3257297A (en) 1998-01-07
JP3784418B2 (ja) 2006-06-14
DE69719320T2 (de) 2003-12-11
EP0896544A1 (de) 1999-02-17
US6362164B1 (en) 2002-03-26
EP0896544B1 (de) 2003-02-26

Similar Documents

Publication Publication Date Title
DE69719320T2 (de) Kombination eines somatostatin analogs und eines rapamycins
HK1022270A1 (en) Use of anti-microtubule agents for treating or preventing multiple-sclerosis
DE69410478T2 (de) Wasserdichter und wasserdampfdurchlässige abdeckung für körperschutz
ATE365051T1 (de) Stabilisierung von rapamycinen oder rapamycinderivaten
TR199701567T1 (xx) Rapamisin t�revleri.
PT914103E (pt) Tratamento de uma hemoglobinopatia
DE69303214T2 (de) Zusammensetzungen und Methoden zur Gaslochbehandlung
DE10199046I2 (de) Rapamycin-Zubereitungen zur oralen Verabreichung
EP0825867A4 (de) N,o-carboxymethylchitosan zur verhinderung operativ bedingter adhäsionen
GB9823878D0 (en) Surgical glove retainer
GB2380939B (en) Treatment or prevention of auto-immune diseases
NO940318L (no) Anordning for behandling av eksosgass
EP0828520A4 (de) Verfahren zum screening von verbindungen, die zur prävention von infektionen oder der pathogenität
DE9317403U1 (de) Mittel zur Verhinderung unangenehmer Gerüche
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
DE69535697D1 (de) Dihydrobenzofurane und verwandte verbindungen als entzündungshemmende mittel
DE9317524U1 (de) Dämpfungsring zur Geräuschreduzierung
GB9222590D0 (en) The treatment of solid organic wastes
KR950033598U (ko) 스로틀 보디의 카본퇴적 방지장치
ID21653A (id) Komposisi untuk pengobatan atau pencegahan pankreatitis yang mengandung turunan diarilalkana sebagai bahan aktif
LTIP1423A (en) Device for treatment of gullet stricture
ECSP961769A (es) Derivados de rapamicina
BR9202934A (pt) Registro de gas deslizante
KR950008925U (ko) 오수 처리장치의 미생물 배양용 접촉제
GR3017993T3 (en) Device for the treatment of waste gases containing gaseous pollutants.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN